Agency for Clinical Innovation
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
最新觀測到的下載價格為 免費。請開啟 App Store 官方連結確認目前結帳價格。
目前在 Apple 公開 App Store 頁面可見的項目,可能不等同於 App Store Connect 中的完整目錄。
來源:Apple 公開 App Store 頁面 · 僅包含公開可見項目
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
根據最新觀測到的 App Store 資料快速解答。
最新觀測到的下載價格為 Free。請開啟 App Store 官方連結確認目前結帳價格。
Apple 公開頁面目前在此商店顯示 0 個購買項目,公開清單可能不完整。